The present application discloses a therapeutic agent for breast cancer, which comprises 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4- yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N- methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.